Francesco Oddone Selected Research

Synthetic Prostaglandins (Prostaglandin Analogues)

10/2022	Topical carbonic anhydrase inhibitors and glaucoma in 2021: where do we stand?
4/2022	A new look at the safety and tolerability of prostaglandin analogue eyedrops in glaucoma and ocular hypertension.
1/2022	A comparison of country-level data from the VISIONARY study examining treatment outcomes with preservative-free tafluprost/timolol fixed-dose combination therapy.
1/2022	Switching to Preservative-Free Tafluprost/Timolol Fixed-Dose Combination in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: Subanalysis of Data from the VISIONARY Study According to Baseline Monotherapy Treatment.
1/2022	Treatment of Open-Angle Glaucoma and Ocular Hypertension with the Fixed-Dose Combination of Preservative-Free Tafluprost/Timolol: Clinical Outcomes from Ophthalmology Clinics in Italy.
1/2020	Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: The VISIONARY Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Francesco Oddone Research Topics

Disease

48	Glaucoma 12/2022 - 04/2004
24	Open-Angle Glaucoma (Glaucoma, Open Angle) 08/2022 - 09/2004
10	Ocular Hypertension (Glaucoma, Suspect) 08/2022 - 01/2015
5	Macular Degeneration (Age-Related Maculopathy) 01/2022 - 03/2009
4	Choroidal Neovascularization 01/2022 - 03/2010
3	Optic Nerve Diseases (Optic Neuropathy) 01/2022 - 01/2019
3	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2021 - 01/2018
3	Inflammation (Inflammations) 01/2021 - 01/2005
3	Blister (Bulla) 01/2021 - 01/2018
3	Cataract (Cataracts) 01/2020 - 01/2018
2	Blindness (Hysterical Blindness) 01/2022 - 07/2020
2	Alzheimer Disease (Alzheimer's Disease) 03/2021 - 11/2015
2	Diabetic Retinopathy (Retinopathy, Diabetic) 03/2021 - 01/2020
2	Parkinson Disease (Parkinson's Disease) 03/2021 - 11/2015
2	Dry Eye Syndromes (Dry Eye Syndrome) 01/2020 - 05/2018
2	Ganglion Cysts (Ganglion) 03/2019 - 12/2015
2	Refractive Errors (Refractive Error) 12/2017 - 01/2014
2	Atrophy 12/2017 - 10/2014
1	Tics (Tic) 12/2022
1	Hyperemia 01/2022
1	Multiple Myeloma 01/2022
1	Wet Macular Degeneration 01/2022
1	Neoplasms (Cancer) 09/2021
1	Neuroinflammatory Diseases 09/2021
1	Ischemic Optic Neuropathy (Anterior Ischemic Optic Neuropathy) 03/2021
1	Brain Ischemia (Cerebral Ischemia) 03/2021
1	Endophthalmitis (Ophthalmia) 01/2021
1	Cysts 08/2020
1	Rett Syndrome (Rett's Disorder) 01/2020
1	Foreign Bodies (Foreign Body) 01/2020
1	Pruritus (Itching) 01/2020
1	Neuroblastoma 01/2020
1	Retinal Detachment (Retinal Detachments) 12/2019
1	Epiretinal Membrane (Epiretinal Membranes) 01/2019
1	Ocular Hypotension 01/2018
1	Myopia 12/2017

Drug/Important Bio-Agent (IBA)

27	Retinaldehyde (Retinal)IBA 03/2022 - 01/2008
11	Timolol (Blocadren)FDA LinkGeneric 08/2022 - 09/2004
8	Cytidine Diphosphate Choline (Citicoline)IBA 03/2021 - 01/2008
7	Ophthalmic Solutions (Eye Drops)IBA 04/2022 - 04/2004
6	Latanoprost (Xalatan)FDA Link 12/2022 - 09/2004
6	Synthetic Prostaglandins (Prostaglandin Analogues)IBA 10/2022 - 01/2020
6	tafluprostIBA 08/2022 - 01/2020
5	Bimatoprost (Lumigan)FDA Link 12/2022 - 09/2004
5	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2022 - 01/2020
5	Ranibizumab (Lucentis)FDA Link 12/2017 - 03/2009
4	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2017
4	Prostaglandins AIBA 01/2022 - 01/2020
3	Pharmaceutical PreparationsIBA 10/2022 - 11/2016
3	Benzalkonium Compounds (Benzalkonium Chloride)FDA LinkGeneric 01/2019 - 01/2014
2	Fluorescein (Funduscein)FDA LinkGeneric 01/2022 - 01/2020
2	Cytidine Monophosphate (CMP)IBA 12/2021 - 01/2019
2	SteroidsIBA 05/2021 - 07/2020
2	Dexamethasone (Maxidex)FDA LinkGeneric 05/2021 - 01/2014
2	GlucocorticoidsIBA 05/2021 - 07/2020
2	Brimonidine Tartrate (Alphagan)FDA LinkGeneric 01/2019 - 04/2004
2	Travoprost (Travatan)FDA Link 01/2019 - 10/2010
2	Hyaluronic Acid (Hyaluronan)IBA 01/2019 - 05/2018
2	ProstaglandinsIBA 06/2016 - 01/2014
1	AcidsIBA 12/2022
1	Carbonic Anhydrase InhibitorsIBA 10/2022
1	Proteasome InhibitorsIBA 01/2022
1	carfilzomibIBA 01/2022
1	Bortezomib (Velcade)FDA Link 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	Chymotrypsin FDA Link 01/2022
1	IntegrinsIBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	Vascular Endothelial Growth Factor CIBA 01/2022
1	Vascular Endothelial Growth Factor DIBA 01/2022
1	AntigensIBA 09/2021
1	Immune Checkpoint InhibitorsIBA 09/2021
1	Glutamic Acid (Glutamate)FDA Link 07/2021
1	CytokinesIBA 07/2021
1	Antiglaucoma AgentsIBA 06/2021
1	Phospholipids (Phosphatides)FDA LinkGeneric 03/2021
1	Cholinergic Agents (Cholinergics)IBA 03/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Fluorouracil (Carac)FDA LinkGeneric 01/2021
1	Ubiquitinated ProteinsIBA 01/2020
1	SolutionsIBA 01/2019
1	brinzolamide (Azopt)FDA Link 01/2019
1	Dihydrotachysterol (AT 10)IBA 11/2018
1	dorzolamide (Trusopt)FDA LinkGeneric 10/2018
1	Taurine FDA Link 05/2018

Therapy/Procedure

17	Therapeutics 12/2022 - 01/2005
5	Trabeculectomy (Trabeculoplasty) 08/2020 - 01/2018
4	Intravitreal Injections 12/2017 - 03/2010
3	Stents 01/2021 - 11/2017
3	Filtering Surgery 12/2020 - 01/2017
3	Phacoemulsification 01/2020 - 01/2018
2	Cataract Extraction 01/2021 - 01/2018
2	Contact Lenses 01/2019 - 04/2004
2	Lasers (Laser) 01/2019 - 11/2015
2	Operative Surgical Procedures 01/2017 - 01/2017
1	Immunotherapy 09/2021
1	Duration of Therapy 07/2020
1	Scleral Buckling 12/2019
1	Aftercare (After-Treatment) 01/2019
1	Vitrectomy 01/2019